News
Article
SCOPE 2023: Future Areas of Investment in Clinical Trials
Author(s):
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures speaks about how the clinical trials sector is evolving, specifically with increased investment in decentralized trials and recent technological advancements such as artificial intelligence and digital biomarkers.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Videos
Related Content
